This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Money and incentives matter, but they are only part of the sales retention story. In any business environment, retaining your best sales producers is a top priority. Today, amid market volatility, changing customer expectations and heightened competition, it’s more important than ever. The warning lights are flashing.
**The 2022 Sales Hiring Forecast has been released – check it out now!**. It’s time for the 6th installment of our annual sales hiring forecast. As there isn’t a hiring forecast specific for b2b sales roles, we started our own forecast in 2015 to help fill this gap. 2019 Sales Hiring in Review. YOY increase.
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. A second, “transitional era” from 2000-2015 was one of older specialty products, including those in multiple sclerosis, early immunological biologics, and oncologics.
Virtual reality is not just a game-changer for medical sales, but a life-changer for all of us. In this episode, Samuel Adeyinka interviews David Howe to explore the world of virtual reality training for medical device sales reps. I love talking about medical devices, software, sales and business. Samuel, I’m doing great.
AbbVie’s internal documents show that from 2015 to 2018, senior executive bonuses were tied directly to Humira’s net revenue, allowing them to profit from AbbVie’s price increases. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars.
Boston is emerging as one of the hottest startup cities in the country, which is great news for sales professionals. These companies are all backed by venture capital and are currently hiring in sales roles. This is by no means an exhaustive list, but here are some great companies to consider for your next sales job. ProfitWell.
The goals are to increase quality, decrease costs and turn health care into a competitive marketplace. They cite a 24% increase in drug costs per hospital admission in 2014 and a 12% increase in 2015. Home healthcare won’t directly impact medical device sales. Better health outcomes will drive sales.
Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. 9,187,405, granted in 2015, which covers a specific dosing regimen for Gilenya (fingolimod) in relapsing-remitting MS. Gilenya made revenues of $2.8
Novartis’ hopes that the Supreme Court would protect its big-selling multiple sclerosis drug Gilenya from generic competition have been dashed. 9,187,405, granted in 2015, which comes to an end in 2027. If they do so, Novartis has predicted it will lose $300 million in sales over the remainder of this year.
Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.
The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.
annually from 2015 to 2020 and is expected to reach $32.14 That means competition is fierce, especially in high-growth locations. Keep reading to learn 10 roofing sales tips you can use to drive more revenue in 2023. These 10 roofing sales tips will put you and your sales team in the best position to succeed.
Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. Gupta cites pregabalin capsules , used to treat epilepsy and nerve pain, as an example, which experienced a 95% price reduction during the first 12 months of generic sales.
Teva launched its first generic in that year with a skinny label that excluded the heart failure use, as it was covered by a use patent that expired in 2015. The substance patent expired in 2007. The post Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug appeared first on.
In the past, the best way to deliver brand messages to prescribers was obvious: send your army of field-based sales representatives to potential high-volume prescribers and sell, sell, sell. But the marketing landscape is decidedly different in today’s digital era.
He had improved sales by tweaking the drink’s flavor slightly, and so was receptive to the idea that changing the flavor of Coke could boost profits. After several price reductions in August 2015, Amazon discontinued the Fire Phone due to poor sales. What went wrong?
Today’s healthcare practitioner must realize that the business of healthcare is a competitive one and it is only through proactively marketing your services to existing and new patients that you will improve your bottom line. These key components are: Operational, for automation of marketing, sales and services for your practice.
B2B sales has evolved over the years. Cold calling and direct mail are still useful for some sales processes, but the way in which we do business has changed a lot. More companies are investing in B2B sales teams — inside and outside — across a range of industries. What Is B2B (Business-to-Business) Sales?
But quite often, the audience is bombarded with retail sales pitches—tons of them—for the likes of AARP, pharma brands, Medicare Advantage, hearing aids, wellness devices, retirement communities, life insurance, cosmetics and many others. Let’s explore how to leverage your message ahead of the competition.
It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler. So what’s driving the growth? .”
Strong competition limits Sandoz's growth. Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. The site employs around 250 people.
Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. When well executed, social listening can be used to inform market research, competitive intelligence, brand planning, and congress engagement initiatives.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content